02:29:02 min
CLEAR ALL
Recently, there has been much excitement in the potential of psychedelic-assisted psychotherapy to address a multitude of mental health conditions, including depression, posttraumatic stress disorder, addiction, end-of-life anxiety, and others. However, not everyone has been included.
2
In this timely webinar - moderated by Chief Psychologist (USA) Dr. Dominique Morisano - clinical psychologist and thought-leader Dr.
PTSD can be very challenging to treat.
This weeks video looks at the effects of MDMA/ecstasy and ketamine as a treatment option for ptsd. The biological mechanisms involved in these drugs for ptsd as well as depression/anxiety are mentioned, as well as the therapeutic benefits and research in the area.
1
Repeated intravenous (IV) ketamine infusions significantly reduce symptom severity in individuals with chronic post-traumatic stress disorder (PTSD) and the improvement is rapid and maintained for several weeks afterwards, according to a study conducted by researchers from the Icahn School of...
Each month The Brain & Behavior Research Foundation hosts a Meet the Scientist Webinar featuring a researcher discussing the latest findings related to mental illness. In June, 2018, the Foundation featured Dr. John H. Krystal of the Yale University School of Medicine.
It is Dr. Patrick’s goal to challenge the status quo and encourage the wider public to think about health and longevity using a proactive, preventative approach.